Rolipram improves renal perfusion and function during sepsis in the mouse

Journal of Pharmacology and Experimental Therapeutics

Volumn 347, Issue 2, 2013, Pages 357-364

  Holthoff, Joseph H ^a   Wang, Zhen ^a   Patil, Naeem K ^a   Gokden, Neriman ^a   Mayeux, Philip R ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; ROLIPRAM; UREA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CAPILLARY PERMEABILITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; KIDNEY FUNCTION; KIDNEY PERFUSION; MALE; MEAN ARTERIAL PRESSURE; MICROCIRCULATION; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; SEPSIS; THERAPY DELAY; UREA NITROGEN BLOOD LEVEL;

ACUTE KIDNEY INJURY; ANIMALS; BLOOD FLOW VELOCITY; DISEASE MODELS, ANIMAL; GLOMERULAR FILTRATION RATE; KIDNEY; MALE; MICE; MICE, INBRED C57BL; MICROCIRCULATION; PHOSPHODIESTERASE 4 INHIBITORS; RENAL CIRCULATION; ROLIPRAM; SEPSIS;

EID: 84885981423     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.113.208520     Document Type: Article

References (56)

1. Bagshaw SM and Bellomo R (2006) Fluid resuscitation and the septic kidney. Curr Opin Crit Care 12:527-530.
2. Begany DP, Carcillo JA, Herzer W.A., Mi Z., and Jackson EK (1996) Inhibition of type IV phosphodiesterase by Ro 20-1724 attenuates endotoxin-induced acute renal failure. J Pharmacol Exp Ther 278:37-41.
3. Brandt S, Regueira T, Bracht H., Porta F, Djafarzadeh S, Takala J., Gorrasi J, Borotto E, Krejci V, and Hiltebrand LB, et al. (2009) Effect of fluid resuscitation on mortality and organ function in experimental sepsis models. Crit Care 13:R186.
4. Carcillo JA, Herzer WA, Mi Z, Thomas N.J., and Jackson EK (1996) Treatment with the type IV phosphodiesterase inhibitor Ro 20-1724 protects renal and mesenteric blood flow in endotoxemic rats treated with norepinephrine. J Pharmacol Exp Ther 279:1197-1204.
5. Cheng J and Grande JP (2007) Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease. Exp Biol Med (Maywood) 232:38-51.
6. Cumming AD, Driedger AA, McDonald J.W., Lindsay RM, Solez K, and Linton AL (1988) Vasoactive hormones in the renal response to systemic sepsis. Am J Kidney Dis 11:23-32.
7. De Backer D., Donadello K, Sakr Y., Ospina-Tascon G, Salgado D, Scolletta S., and Vincent JL (2013) Microcirculatory alterations in patients with severe sepsis: impact of time of assessment and relationship with outcome. Crit Care Med 41: 791-799.
8. Doi K, Leelahavanichkul A, Yuen P.S., and Star RA (2009) Animal models of sepsis and sepsis-induced kidney injury. J Clin Invest 119:2868-2878.
9. Dubin A, Pozo MO, Casabella C.A., Pálizas F, Jr, Murias G, Moseinco MC, Kanoore Edul VS, Pálizas F, Estenssoro E, and Ince C (2009) Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study. Crit Care 13:R92.
10. Dudley C (2004) Maximizing renal preservation in acute renal failure. BJU Int 94: 1202-1206.
11. Frossard N, Landry Y, Pauli G., and Ruckstuhl M (1981) Effects of cyclic AMP- and cyclic GMP-phosphodiesterase inhibitors on immunological release of histamine and on lung contraction. Br J Pharmacol 73:933-938.
12. Gomes A, Fernandes E, and Lima JL (2006) Use of fluorescence probes for detection of reactive nitrogen species: a review. J Fluoresc 16:119-139.
13. Halliwell B and Whiteman M (2004) Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 142:231-255.
14. Heemskerk S, Masereeuw R, Russel F.G., and Pickkers P (2009) Selective iNOS inhibition for the treatment of sepsis-induced acute kidney injury. Nat Rev Nephrol 5:629-640.
15. Holthoff JH, Wang Z, Seely K.A., Gokden N., and Mayeux PR (2012) Resveratrol improves renal microcirculation, protects the tubular epithelium, and prolongs survival in a mouse model of sepsis-induced acute kidney injury. Kidney Int 81: 370-378.
16. Ince C (2005) The microcirculation is the motor of sepsis. Crit Care 9 (Suppl 4): S13-S19.
17. Kalakeche R, Hato T, Rhodes G., Dunn KW, El-Achkar TM, Plotkin Z, Sandoval R.M., and Dagher PC (2011) Endotoxin uptake by S1 proximal tubular segment causes oxidative stress in the downstream S2 segment. J Am Soc Nephrol 22:1505-1516.
18. Le Dorze M., Legrand M, Payen D., and Ince C (2009) The role of the microcirculation in acute kidney injury. Curr Opin Crit Care 15:503-508.
19. Lee WL and Slutsky AS (2010) Sepsis and endothelial permeability. N Engl J Med 363:689-691.
20. Lin YC, Samardzic H, Adamson R.H., Renkin EM, Clark JF, Reed RK, and Curry FR (2011) Phosphodiesterase 4 inhibition attenuates atrial natriuretic peptide-induced vascular hyperpermeability and loss of plasma volume. J Physiol 589: 341-353.
21. Liu S, Yu C, Yang F., Paganini-Hill A, and Fisher MJ (2012) Phosphodiesterase inhibitor modulation of brain microvascular endothelial cell barrier properties. J Neurol Sci 320:45-51.
22. Lugnier C (2006) Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol Ther 109: 366-398.
23. Lundy DJ and Trzeciak S (2009) Microcirculatory dysfunction in sepsis. Crit Care Clin 25:721-731, viii.
24. Mayeux PR and MacMillan-Crow LA (2012) Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury. Pharmacol Ther 134:139-155.
25. Millar CGM and Thiemermann C (1997) Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition. Br J Pharmacol 121:1824-1830.
26. Miotla JM, Teixeira MM, and Hellewell PG (1998) Suppression of acute lung injury in mice by an inhibitor of phosphodiesterase type 4. Am J Respir Cell Mol Biol 18: 411-420.
27. Miyaji T, Hu X, Yuen P.S., Muramatsu Y., Iyer S, Hewitt SM, and Star RA (2003) Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice. Kidney Int 64:1620-1631.
28. Morin AM and Stanboli AS (1994) Nitric oxide synthase localization in cultured cerebrovascular endothelium during mitosis. Exp Cell Res 211:183-188.
29. Netherton SJ and Maurice DH (2005) Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis. Mol Pharmacol 67:263-272.
30. Paxian M, Keller SA, Cross B, Huynh T.T., and Clemens MG (2004) High-resolution visualization of oxygen distribution in the liver in vivo. Am J Physiol Gastrointest Liver Physiol 286:G37-G44.
31. Rackow EC and Astiz ME (1991) Pathophysiology and treatment of septic shock. JAMA 266:548-554.
32. Rangel-Frausto M.S., Pittet D, Costigan M., Hwang T, Davis CS, and Wenzel RP (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273:117-123.
33. Rivers E, Nguyen B, Havstad S., Ressler J, Muzzin A, Knoblich B., Peterson E, and Tomlanovich M; Early Goal-Directed Therapy Collaborative Group (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368-1377.
34. Russell JA (2006) Management of sepsis. N Engl J Med 355:1699-1713.
35. Salgado DR, Rocco JR, Silva E, and Vincent JL (2010) Modulation of the renin-angiotensin-aldosterone system in sepsis: a new therapeutic approach? Expert Opin Ther Targets 14:11-20.
36. Sandner P, Kornfeld M, Ruan X., Arendshorst WJ, and Kurtz A (1999) Nitric oxide/cAMP interactions in the control of rat renal vascular resistance. Circ Res 84:186-192.
37. Schick MA, Wunder C, Wollborn J., Roewer N, Waschke J, Germer C.T., and Schlegel N (2012) Phosphodiesterase-4 inhibition as a therapeutic approach to treat capillary leakage in systemic inflammation. J Physiol 590:2693-2708.
38. Schrier RW and Wang W (2004) Acute renal failure and sepsis. N Engl J Med 351: 159-169.
39. Seely KA, Holthoff JH, Burns S.T., Wang Z., Thakali KM, Gokden N, Rhee SW, and Mayeux PR (2011) Hemodynamic changes in the kidney in a pediatric rat model of sepsis-induced acute kidney injury. Am J Physiol Renal Physiol 301: F209-F217.
40. Souza DG, Cassali GD, Poole S, and Teixeira MM (2001) Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusion injury. Br J Pharmacol 134:985-994.
41. Tanahashi M, Hara S, Yoshida M., Suzuki-Kusaba M, Hisa H, and Satoh S (1999) Effects of rolipram and cilostamide on renal functions and cyclic AMP release in anesthetized dogs. J Pharmacol Exp Ther 289:1533-1538.
42. Tiwari MM, Brock RW, Megyesi J.K., Kaushal GP, and Mayeux PR (2005) Disruption of renal peritubular blood flow in lipopolysaccharide-induced renal failure: role of nitric oxide and caspases. Am J Physiol Renal Physiol 289:F1324-F1332.
43. Torphy TJ and Cieslinski LB (1990) Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle. Mol Pharmacol 37:206-214.
44. Trzeciak S, Dellinger RP, Parrillo J.E., Guglielmi M., Bajaj J, Abate NL, Arnold R.C., Colilla S., Zanotti S, and Hollenberg SM; Microcirculatory Alterations in Resuscitation and Shock Investigators (2007) Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to hemodynamics, oxygen transport, and survival. Ann Emerg Med 49:88-98, e1-e2.
45. Vallon V, Traynor T, Barajas L., Huang YG, Briggs JP, and Schnermann J (2001) Feedback control of glomerular vascular tone in neuronal nitric oxide synthase knockout mice. J Am Soc Nephrol 12:1599-1606.
46. Venkatachalam MA and Weinberg JM (2012) The tubule pathology of septic acute kidney injury: a neglected area of research comes of age. Kidney Int 81:338-340.
47. Wan L, Bellomo R, Di Giantomasso D, and Ronco C (2003) The pathogenesis of septic acute renal failure. Curr Opin Crit Care 9:496-502.
48. Wang W, Zolty E, Falk S., Basava V, Reznikov L, and Schrier R (2006) Pentoxifylline protects against endotoxin-induced acute renal failure in mice. Am J Physiol Renal Physiol 291:F1090-F1095.
49. Wang Z, Herzog C, Kaushal G.P., Gokden N., and Mayeux PR (2011) Actinonin, a meprin A inhibitor, protects the renal microcirculation during sepsis. Shock 35:141-147.
50. Wang Z, Holthoff JH, Seely K.A., Pathak E., Spencer HJ, 3rd, Gokden N, and Mayeux PR (2012) Development of oxidative stress in the peritubular capillary microenvironment mediates sepsis-induced renal microcirculatory failure and acute kidney injury. Am J Pathol 180:505-516.
51. Wu L and Mayeux PR (2007) Effects of the inducible nitric-oxide synthase inhibitor L-N(6)-(1-iminoethyl)-lysine on microcirculation and reactive nitrogen species generation in the kidney following lipopolysaccharide administration in mice. J Pharmacol Exp Ther 320:1061-1067.
52. Wu L, Gokden N, and Mayeux PR (2007a) Evidence for the role of reactive nitrogen species in polymicrobial sepsis-induced renal peritubular capillary dysfunction and tubular injury. J Am Soc Nephrol 18:1807-1815.
53. Wu L, Tiwari MM, Messer K.J., Holthoff JH, Gokden N, Brock RW, and Mayeux PR (2007b) Peritubular capillary dysfunction and renal tubular epithelial cell stress following lipopolysaccharide administration in mice. Am J Physiol Renal Physiol 292:F261-F268.
54. Wunder C, Brock RW, Krug A, Roewer N., and Eichelbrönner O (2005) A remission spectroscopy system for in vivo monitoring of hemoglobin oxygen saturation in murine hepatic sinusoids, in early systemic inflammation. Comp Hepatol 4:1.
55. Yasuda H, Yuen PS, Hu X, Zhou H., and Star RA (2006) Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects. Kidney Int 69: 1535-1542.
56. Zager RA, Johnson AC, Lund S, Hanson S.Y., and Abrass CK (2006) Levosimendan protects against experimental endotoxemic acute renal failure. Am J Physiol Renal Physiol 290:F1453-F1462.